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Abstract The McKee-Farrar (MF) prosthesis was the ﬁrst
widely used total hip replacement (THR) to employ a metal-
on-metal (MoM) articulation. These implants had a high
rate of early aseptic loosening but a number achieved good
long-term implant survival, stimulating the reintroduction of
second and third generation implants of this type. In this
study we analysed archival histopathology of periprosthetic
tissues in twenty cases of MF aseptic implant failure to
determine if there was evidence of an innate and adaptive
immune response similar to that seen in modern MoM
implants. The presence of macrophages, the extent of
necrosis and the ALVAL response were graded semi-
quantitatively. Variable but in most cases extensive tissue
necrosis was associated with a heavy macrophage response
to Cobalt-Chrome (Co-Cr) wear particles in periprosthetic
tissues; most cases also contained evidence of a pre-
dominantly lymphocyte response which in eight cases was
moderate or heavy (Oxford Grade 2/3). Our ﬁndings show
that inﬂammatory and necrotic changes to deposition of Co-
Cr wear particles are found in periprosthetic tissues of failed
MF implants, indicating that there is an innate and adaptive
response similar to that noted in second/third generation
MoM implants; they also suggest that the pathobiological
response to metal wear particles is likely to have contributed
to MF implant failure in these cases.
Graphical Abstract
1 Introduction
G.K. McKee and J Watson-Farrar developed a metal on
metal (MoM) hip joint prosthesis for total hip replacement
(THR) in the 1960s [1–4]. Large numbers of these metal-
on-metal (MoM) implants were implanted but they even-
tually fell out of favour when superior outcomes were
reported with the low-friction Charnley metal on poly-
ethylene (MoP) prosthesis. It was noted that McKee-Farrar
(MF) hip replacements had a high rate of aseptic loosening
in the ﬁrst 10 years; McKee stopped using the all-metal
system in 1972 [1]. Failure of MF implants was thought to
be due mainly to poor implant design [1, 5]. The stem of the
femoral component was curved with narrow medial and
lateral borders and had multiple sharp corners [1, 6]. These
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features resulted in areas of high localised stress within the
cement mantle; the broad neck of the MF femoral compo-
nent was also prone to impingement against the metal rim of
the acetabular component. The original surgical technique
for implantation did not include reaming and routine dee-
pening of the acetabulum, and, as a result, the components
did not have adequate lateral bone cover [1, 6]. Despite
these shortcomings, some MF hip replacements have shown
impressive survival outcomes with several lasting more than
20 years [5–10].
The relative success of some MF and other ﬁrst-
generation MoM implant designs stimulated the drive to
develop second- and third-generation MoM hip implants
[11]. The modern MoM implants are composed of a cobalt-
chrome molybdenum alloy similar to that used in the MF
implant. Although some second and third-generation MoM
designs have performed reasonably, a number have been
associated with implant failure [12–14]. This is considered
to be due in large measure to the pathobiological response
to deposition of cobalt–chrome (Co–Cr) wear particles in
periprosthetic tissues in which extensive necrosis an innate
and foreign body macrophage response to Co–Cr wear is
often seen as well as prominent lymphoid inﬁltrate which is
characteristically perivascular in distribution; this has been
termed ALVAL (aseptic lymphocyte-dominated vasculitis-
associated lesion) and is believed to reﬂect the adaptive
immune response to Co–Cr wear in periprosthetic tissues
[13, 15–21].
There are relatively few reports on the histopathology of
failed MF hip implants; some of these noted pathological
changes similar to those reported in second- and third-
generation MoM hip implants [22–27]. With one exception
[22], these studies examined only a handful of cases. In this
study, we have analysed histopathological ﬁndings in
periprosthetic tissues around twenty failed MF hip implants
with regard to the inﬂammatory and necrotic changes
known to be associated with second- and third-generation
MoM hip implants. Our aim has been to determine whether
Co-Cr particles from MF implants induced a similar
pathobiological response in periprosthetic tissues, particu-
larly with regard to the necrotic and inﬂammatory changes
that reﬂect the innate (non-speciﬁc) and adaptive (speciﬁc)
host immune response to deposition of Co–Cr wear
particles.
2 Materials and methods
Periprosthetic tissue histology from twenty cases of failed
MF hip implants undergoing revision arthroplasty for
aseptic loosening were obtained from the ﬁles of the His-
topathology Department, Nufﬁeld Orthopaedic Centre,
Oxford. The cases studied included 15 females and 5 males;
the age range of the patients was 55 to 84 years. The ori-
ginal hip arthroplasty procedure was carried out between
1968 and 1974 and revision surgery was carried out
between 1975 and 2008. There was limited clinical infor-
mation and radiology for most cases was not available.
Implant duration was 2 to 41 years. Clinical information
provided on the pathology forms noted that the specimens
were associated with “failure” of an MF hip implant: eleven
of the cases referred to “loosening” of an MF implant. Two
cases of sepsis were excluded. Details of patient age and
implant duration are shown in Table 1.
The tissues analysed were the joint capsule in all cases
and the femoral and/or acetabular membrane in 10 cases.
The tissues were ﬁxed in 10% formalin, embedded in par-
afﬁn wax, sectioned and stained with haematoxylin-eosin.
Tissue necrosis and the extent of the inﬂammatory cell
inﬁltrate in MoM periprosthetic tissues was assessed semi-
quantitatively by histology as previously described [16, 17].
The number of macrophages was scored as 0 (absent), 1+
(few), 2+ (many), 3+ (abundant); necrosis was scored as 0
(absent), 1+ (scattered small necrotic areas), 2+ (frequent
small or large necrotic areas: up to 25% tissue involve-
ment), 3+ (extensive necrosis: more than 25% tissue
involvement). The perivascular lymphoid inﬁltrate was
graded using the Oxford ALVAL scoring system [16], this
has been shown to correlate well with the Campbell scoring
system [28]. In the Oxford System, grade 0= no evidence
of perivascular lymphocyte inﬁltrate; grade 1= little evi-
dence of a perivascular lymphocytic inﬁltrate, with lym-
phocyte cufﬁng of vessels being fewer than ﬁve cells in
thickness; grade 2= several perivascular lymphoid aggre-
gates, with lymphocytic cufﬁng of vessels being ﬁve to ten
cells in thickness; and grade 3= numerous large perivas-
cular lymphoid aggregates, with lymphocyte cufﬁng around
vessels being more than ten cells in thickness.
Immunohistochemistry was carried out using an indirect
immunoperoxidase technique to determine the antigenic
phenotype of phagocytic macrophages and lymphoid cells
in the inﬂammatory inﬁltrate of periprosthetic tissues. The
list of monoclonal antibodies used in this study and their
antigen speciﬁcity is shown in Table 2.
3 Results
The most notable feature seen in the joint capsule and
periprosthetic ﬁbrous tissue membrane of all MF implant
failures was a variable but generally extensive degree of
surface tissue necrosis associated with an underlying heavy
foreign body macrophage inﬁltrate (Fig. 1a). The tissues
had a prominent zone of surface necrosis in which there
were viable macrophages and occasional giant cells con-
taining Co-Cr particles; some macrophages showed changes
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of apoptosis such as nuclear pyknosis (Fig. 1b). Beneath
this zone there was a prominent macrophage inﬁltrate.
Viable macrophages had vesicular nuclei and discrete
plump cytoplasm which contained granular brown or black
particles, indicating Co–Cr wear particle phagocytosis
(Fig. 2a). On the surface, there was macrophage necrosis
and apoptosis, evident as loss of cytoplasmic outline,
nuclear pyknosis and release of wear particles into the
degenerate tissue matrix (Fig. 2b). Histological ﬁndings
regarding the extent of necrosis and macrophage inﬁltration
are summarised in Table 1. A heavy eosinophil polymorph
inﬁltrate was noted in two specimens. A few neutrophil
polymorphs (less than 1 per high power ﬁeld on average)
were noted in two specimens.
In all but two of the cases, the sampled periprosthetic
tissues contained a scattered, focally heavy lymphocyte
inﬁltrate (Table 1); plasma cells were seen in three cases.
Eight cases (some of which were associated with relatively
short implant duration) had a moderate or heavy lympho-
cyte inﬁltrate with Grade 2/3 Oxford ALVAL scores
(Fig. 3). In nine cases the Oxford ALVAL score was Grade
1. There were three cases in which The Oxford ALVAL
score was 0; in these cases, specimens of the capsule were
composed entirely of necrotic tissue with only a few scat-
tered macrophages and no obvious lymphocyte inﬁltrate.
Immunohistochemistry showed that the mononuclear
phagocytic cells containing metal wear particles strongly
expressed the monocyte/macrophage markers CD14, CD68
(Fig. 4a) and CD163; these cells also strongly expressed
HLA-DR. Lymphocytes in the perivascular lymphoid
aggregates expressed the T-cell marker CD3 (Fig. 4b). A
few cells also expressed the B-cell marker CD20. Most CD3
+ T cells also expressed CD4, a marker of T-helper cells,
with a minority of cells weakly expressing CD8, which is
characteristic of T-cytotoxic/suppressor cells. Weak
expression of the apoptosis marker bcl-2 was noted in
macrophages and some lymphoid cells.
Table 1 Case details and
pathological ﬁndings in 20 failed
McKee–Farrar hip implants
Case details Pathological ﬁndings
Case No. Sex Age at revision Implant duration (year) Necrosis Macrophage Oxford ALVAL score
1 F 73 3 3 3 3
2 F 71 3 3 3 3
3 M 39 3 3 3 0
4 F 44 4 3 3 3
5 F 63 4 3 3 0
6 F 84 4 2 2 1
7 F 68 5 3 2 1
8 F 72 5 3 3 3
9 F 83 5 3 2 1
10 F 85 7 2 3 2
11 M 62 7 3 3 1
12 F 70 9 3 3 2
13 M 73 9 3 3 3
14 M 55 14 3 1 0
15 F 84 25 3 3 1
16 F 61 27 3 3 1
17 F 78 28 3 3 1
18 M 68 30 3 3 1
19 F 57 33 3 3 1
20 F 74 41 3 3 2
Table 2 Antigen speciﬁcity of monoclonal antibodies used in this
study
Antibody (clone) Antigen speciﬁcity Source
F7.2.38 CD3: T cells Dakopatts
NCL-L-CD4-368 CD4: T helper cells Novocastra
CR/144B CD8: T suppressor cells Dakopatts
CD14-223 CD14: monocytes macrophages Novocastra
L26 CD20: B cells Dakopatts
KP1 CD68: monocytes macrophages Dakopatts
CR3/43 HLA-DR Dakopatts
124 BCL-2 oncoprotein: apoptosis Dakopatts
NCL-CD163 CD163: macrophages Novocastra
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4 Discussion
Although the MoM MF total hip prosthesis was char-
acterised by a higher rate of early- and intermediate-term
aseptic loosening than the MoP Charnley implant, a few
studies reported similar rates of long-term implant loosen-
ing. Jacobsson et al. [9] reported a 20 year implant survival
of 77% in 107 consecutive MF arthroplasties; this compared
with 73% for a similar population with the Charnley pros-
thesis. Brown et al. [29] reported a 28 year MF implant
survivorship of 74% and noted that the reported survival of
MoM total hip arthroplasties was 53–89% at 10 to 15 years
while that of the Charnley arthroplasty was 75–84% over 20
to 30 years. A review of short-term outcomes of the ﬁrst
100 cases that received a MF hip implant in Oxford reported
good or excellent results in 90% of cases [30]. A subsequent
Fig. 1 a Histology of
periprosthetic ﬁbrous tissue
membrane from a failed MF
implant showing necrosis on the
surface with underlying foreign
body macrophage inﬁltrate. b
High power view of area of
surface necrosis in 1a. showing a
viable giant cell and
macrophages with vesicular
nuclei (some marked by thick
arrows); phagocytosed
aggregates of metal wear
particles are evident as a black
dot in the cytoplasm. There are
also apoptotic macrophages with
pyknotic nuclei (some marked
by thin arrows)
Fig. 2 Histology of
periprosthetic tissue from a
failed MF implant showing: a
viable macrophages with
phagocytosed (brown-black)
Co–Cr wear particles of variable
size (some arrowed) b necrotic
and apoptotic macrophages with
released wear particles (some
arrowed) (color ﬁgure online)
Fig. 3 Histology of
periprosthetic tissue membrane
from a failed MF implant
showing: a a zone of surface
necrosis beneath which there are
several perivascular lymphoid
aggregates (some arrowed). b
High power view of lymphoid
aggregates in 3a
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review comparing results of the MF and the Charnley total
hip prosthesis in over 200 cases reported superior clinical
outcomes and fewer complications with the Charnley
implant [31]. Amstutz and Grigoris reviewed the clinical
results of MF and other ﬁrst- generation MoM hip implants
and noted, as in the present study, some impressive out-
comes [1].
The main cause of early MF hip implant failure was
aseptic loosening. This complication was ascribed mainly to
the MF implant being biomechanically at a disadvantage
compared with the Charnley implant in design terms [1, 2,
5, 6]. A number of reports, however, noted pathological
changes in periprosthetic tissues that were proposed as
contributory factors to the development of implant loosen-
ing. Evans et al. [24] reported necrosis of bone and capsular
tissue around MoM hip implants and noted a correlation
with the severity and extent of obliterative changes in
vessels; it was suggested that these changes occurred as a
result of a sensitivity reaction to Co-Cr ions derived from
metal wear particles. Winter [27] described necrosis in tis-
sues around retrieved MoM hip replacements with particles
deposited in acellular collagen and in phagocytic cells Jones
et al. [26] also reported necrosis of bone and capsular tissue
from retrieved ﬁrst-generation MoM prostheses and attrib-
uted this to a toxic and hypersensitivity reaction to cobalt
which he suggested caused an avascular phenomenon. The
study of Brown et al. [22] noted signiﬁcant tissue necrosis
and a chronic inﬂammatory cell inﬁltrate in soft tissue and
bone; metallic debris within cells and a prominent lym-
phocytic inﬁltrate with occasional plasma cells were also
identiﬁed. Doorn et al. [23] and Howie et al. [25] also noted
tissue necrosis and the presence of lymphocytes in retrieved
periprosthetic tissues around MF and other ﬁrst-generation
MoM hip implants. Willert et al. [32], investigating (non-
MF) failed ﬁrst-generation MoM total hip arthroplasties,
also noted a lymphocyte response in peri-implant tissues.
Other studies allude to the presence of macrophages and
giant cells, but do not mention tissue necrosis or a lymphoid
inﬁltrate [7, 33–35].
The MF hip implant was composed of a similar Co–Cr
alloy to that used in second- and third-generation MoM
implants. In this study we show that periprosthetic tissues
around MF implants exhibit similar pathological changes to
those reported around modern MoM implants. Cell and
tissue necrosis, a heavy inﬁltrate of macrophages in
response to Co–Cr wear particles and ALVAL-like lym-
phoid aggregates, commonly seen in failed modern MoM
hip implants [15–20, 36, 37], were also noted in failed MF
hip implants with approximately 40% of cases exhibiting a
Grade 2/3 ALVAL response.
The MoM articulation tends to produce less volumetric
wear than other implant combinations such as MoP; how-
ever, the number of wear particles generated is an order of
magnitude higher, the particles being much smaller and
therefore much more numerous per unit volume [38, 39].
The nanometre-size Co–Cr particles induce a profound
innate and adaptive immune response. Macrophage pha-
gocytosis of metal wear particles is probably the major
factor in causing the extensive necrosis in MoM peripros-
thetic tissues. Co–Cr particles are subject to corrosion and
produce high levels of metal ions which are cytotoxic,
causing apoptosis and necrosis of macrophages that release
lysosomal enzymes into the tissues. Metal ions can also act
as haptens, combining with cell and tissue proteins to
induce a speciﬁc cell-mediated delayed hypersensitivity
immune response. This is evidenced histologically in MoM
implants by the presence of a predominantly T lymphocyte
inﬁltrate which is often perivascular in nature [17, 36, 37].
T cells predominated in the lymphoid aggregates seen in
failed MF cases, suggesting that the adaptive immune
response to metal wear is similar.
The presence of profound necrotic and inﬂammatory
changes in the MF periprosthetic tissues would indicate that
Co–Cr wear particle-induced hypersensitivity and cyto-
toxicity are likely to have contributed, at least in part, to
implant failure. A major limitation of our study is that, due
to the many years that have elapsed, we do not have full
clinical and radiological information on the cases we have
Fig. 4 Immunohistochemistry
of periprosthetic tissue
membrane from a failed MF
implant showing a staining of
foreign body macrophages for
CD68 (pan-macrophage marker)
and b staining of perivascular
lymphocytes for CD3 (T cell
marker)
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analysed. Pseudotumours have been strongly associated
with failure of modern MoM hip implants [15, 16, 19, 20]
and, though not seen in our cases, there are two reports of
probable pseudotumour-like lesions associated with MF
implant failure [23, 40].
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